TAA
GILD icon

TB Alternative Assets’s Gilead Sciences GILD Stock Holding History

TB Alternative Assets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-36,700
Closed -$2.3M – 26
2018
Q4 		$2.3M Sell
36,700
-15,800
-30% -$1.1M 0.93% 17
2018
Q3 		$4.05M Sell
52,500
-26,900
-34% -$2.03M 1.5% 14
2018
Q2 		$5.63M Buy
79,400
+13,100
+20% +$925K 1.71% 11
2018
Q1 		$5M Sell
66,300
-45,500
-41% -$3.62M 2.06% 10
2017
Q4 		$8.01M Buy
111,800
+91,600
+453% +$6.96M 2.98% 6
2017
Q3 		$1.64M Sell
20,200
-19,400
-49% -$1.48M 0.59% 11
2017
Q2 		$2.8M Buy
39,600
+1,500
+4% +$99.8K 1.3% 12
2017
Q1 		$2.59M Buy
+38,100
New +$2.68M 1.86% 9

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TB Alternative Assets's GILD Position: Q1 2019 in Review

TB Alternative Assets sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 36,700 shares — an estimated $2.3M sold.

TB Alternative Assets first reported a position in GILD in Q1 2017 and held it in 8 quarters. The position peaked at $8.01M in Q4 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • TB Alternative Assets reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • TB Alternative Assets sold 36,700 Gilead Sciences shares in Q1 2019, an estimated $2.3M.
  • TB Alternative Assets first reported a position in Gilead Sciences in Q1 2017 and held it in 8 quarters.
  • TB Alternative Assets's Gilead Sciences position peaked at $8.01M in Q4 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on TB Alternative Assets's 13F filing for Q1 2019, filed 18 Apr 2019.